Nontuberculous Mycobacteria News and Research

RSS
Just as with plants, germs are segregated into a variety of categories, known as families. The Mycobacteriaceae family represents one family of bacteria. Several species exist in the Mycobacteriaceae family but only certain species, known as pathogenic Mycobacteriaceae, can lead to the onset of human disease. Other species, termed saprophytic Mycobacteriaceae, do not lead to the onset of human disease or illness.
Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

Experts create new, evidence-based guideline for treatment of NTM lung disease

Experts create new, evidence-based guideline for treatment of NTM lung disease

Study shows non-TB lung infections rising; more in women and older people

Study shows non-TB lung infections rising; more in women and older people

Researchers develop new method to accurately identify nontuberculous mycobacteria

Researchers develop new method to accurately identify nontuberculous mycobacteria

Slime in showerheads could harbour dangerous lung bacteria finds study

Slime in showerheads could harbour dangerous lung bacteria finds study

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Inhaled steroid use linked to greater risk of NTM lung infections

Inhaled steroid use linked to greater risk of NTM lung infections

Understanding the rise in NTM infections

Understanding the rise in NTM infections

DNA links deadly germs, tainted heart surgery devices to German factory

DNA links deadly germs, tainted heart surgery devices to German factory

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

NTM lung infections

NTM lung infections

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen